SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-11-006271
Filing Date
2011-11-02
Accepted
2011-11-02 08:01:51
Documents
2
Period of Report
2011-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CELLDEX THERAPEUTICS, INC. 8-K a50052759.htm 8-K 15882
2 EXHIBIT 99.1 a50052759_ex991.htm EX-99.1 77877
  Complete submission text file 0001157523-11-006271.txt   95056
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 111173066
SIC: 2835 In Vitro & In Vivo Diagnostic Substances